Abstract:Objective To investigate the antibiotic resistance of extended-spectrum-β-1actamases (ESBLs)-producing Escherichia coli (E.coli) and Klebsiella pneumoniae (K.pneumoniae) isolates and the risk factors of bloodstream infections caused by these strains.Methods Clinical data of 131 patients with E.coli or K.pneumoniae-induced bloodstream infections admitted in the Second Affiliated Hospital of Zhejiang Chinese Medical University during September 2009 and June 2014 were retrospectively analyzed.Species identification and antimicrobial susceptibility test were performed by Vitek 2 system,and ESBLs production was tested by standard disk diffusion method.Logistic regression analysis was performed to identify the risk factors of bloodstream infections induced by ESBLs-producing strains.Results Among 131 patients,65 were infected with ESBLs-producing strains,and 66 were infected with non-ESBLs-producing strains.The resistance rates of ESBLs-producing strains were above 50％ for penicillin,aztreonam and third/fourth generation cephalosporins,which were significantly higher than those of non-ESBLs producing strains.The resistance rates of ESBLs-producing E.coli and K.pneumoniae to carbapenems and piperacillin/tazobactam were 0-2.0％,2.3％ and 0-14.3％,26.7％,respectively.The univariate analysis revealed that patients with exposure to cephalosporins in recent 3 months (x2 =18.322,P ＜ 0.01),prior infection with ESBLs-producing strains (x2=14.610,P＜0.01),indwelling catheter in recent 3 months (x2 =13.016,P ＜ 0.01),history of hospitalization in recent 3 months (x2 =11.269,P ＜ 0.01),exposure to quinolones in recent 3 months (x2 =10.638,P ＜ 0.01),nosocomial infection (x2 =8.205,P ＜ 0.01),history of indwelling deep venous catheter or percutaneous central catheter in recent 3 months (x2 =4.817,P ＜ 0.05) and exposure to glucocorticoid hormone in recent 3 months (x2 =4.265,P ＜ 0.05) were associated with infection of ESBLs-producing strains.Multivariate Logistic regression analysis revealed that exposure to quinolones in recent 3 months (OR =6.851,P ＜ 0.01),prior infection with ESBLs-producing strains (OR =6.344,P ＜ 0.01),exposure to cephalosporins in recent 3 months (OR =3.719,P ＜ 0.01),and indwelling catheter in recent 3 months (OR =3.180,P ＜ 0.05) were independent risk factors for ESBLs-producing E.coli or K.pneumoniae infection.Conclusions ESBLs-producing E.coli or K.pneumoniae isolates are highly resistant to most antibiotics,and multidrug-resistance is common.Carbapenems were still the most effective antibiotics against ESBLs-producing E.coli or K.pneumoniae infection.Rational use of cephalosporins and quinolones,strictly following aseptic technique in operation,strict use of indications for indwelling catheterization,and completely eradicating ESBLs-producing strains in previous infections may be helpful in reducing bloodstream infections by ESBLs-producing E.coli or K.pneumoniae.

Extended-spectrum Beta-lactamases-producing Enterobacteriaceae in ICU Patients with Infection:Their Drug Resistance Analysis

Molecular Characteristics of Extended-Spectrum Β-Lactamase-producing Escherichia Coli and Klebsiella Pneumoniae Causing Intra-Abdominal Infections from 9 Tertiary Hospitals in China

Antibiotic resistance of ESBLs-producing Escherichia coli and Klebsiella pneumoniae isolates and risk factors for bloodstream infections

Study on Antibiotics Resistance of Extended-Spectrum Β-Lactamases-producing Escherichia Coil and Klebsiella Pneumoniae in Hangzhou

Analysis of the Drug Resistance of Extended-Spectrum Β-Lactamase(esbl)-producing Escherichia Coli in Cancer Patients

[Extended-Spectrum Beta-Lactamase in Klebsiella Pneumoniae and Escherichia Coli Isolates].

[Drug-Resistance Analysis of Gram-negative Bacilli Producing Extended-Spectrum Beta-Lactamases in Lower Respiratory Tract Infection].

Drug Resistance of Escherichia Coli Causing Blood Stream Infections

Resistance of Strains Producing Extended-Spectrum Β-Lactamases and Genotype Distribution in China

Detection of Producing Extended-Spectrum Β-Lactamases (esbls) and the Analysis of Drug Susceptivity

Resistance Surveillance of 400 Gram-negative Bacterial Isolates from Intensive Care Unit with E-test

Extended-spectrum β-Lactamases-producing Klebsiella pneumoniae and Escherichia coli:Distribution and Drug-resistance Analysis

Molecular Epidemiologic Study of Extended-Spectrum Beta-Lactamase in Escherichia Coli and Klebsiella Pnenmoniae

Drug resistance and risk factors of extended spectrum-β lactamases producing Escherchia coli and Klebsiella pneumoniae

[Genotype of Extended-Spectrum Beta-Lactamases Produced by Antibiotic-Resistant Escherichia Coli and Klebsiella Pneumoniae in Surgical Intensive Care Unit].

Investigation of extended-spectrum β-lactamase in Klebsiellae pneumoniae and Escherichia coli from China

Clinical analysis of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases in patients with respiratory tract infection

Distribution of extended spectrum β-lactamase producing strains and their antibiotics resistance

Study on Antimicrobial Resistance and Detection of AmpC and Extended-Spectrum Β-Lactamases-producing Strains in a Respiratory Intensive Care Unit

The resistance spectrum of escherichiacoli in bloodstream infection

Examination and Resistance Analysis of Escherichia coli and Klebsiella pneumonia Producing Extended-Spectrum β-Lactamases